Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Mar 5;13(5):e033925.
doi: 10.1161/JAHA.124.033925. Epub 2024 Feb 29.

eGFR Trajectory in LVAD Recipients with Right Heart Failure: Status Quo or a Steady Decline?

Bethany Roehm  1 , Arianne C Agdamag  2
Affiliations
Editorial

eGFR Trajectory in LVAD Recipients with Right Heart Failure: Status Quo or a Steady Decline?

Bethany Roehm et al. J Am Heart Assoc. .
No abstract available

Keywords: Editorials; LVAD; eGFR; right heart failure.

PubMed Disclaimer

Figures

Figure .
Figure .. Pathophysiology of the interplay between right heart failure and kidney disease.
eGFR indicates estimated glomerular filtration rate; FGF23, fibroblast growth factor 23; HF, heart failure; IAP, intra‐abdominal pressure; LV, left ventricular; LVAD, left ventricular assist device; RAAS, renin‐angiotensin‐aldosterone system; RV, right ventricular; SNS, sympathetic nervous system; and SVP, systemic venous pressure.
See this image and copyright information in PMC

Comment on

References

    1. Konstam MA, Kiernan MS, Bernstein D, Bozkurt B, Jacob M, Kapur NK, Kociol RD, Lewis EF, Mehra MR, Pagani FD, et al. Evaluation and management of right‐sided heart failure: a scientific statement from the American Heart Association. Circulation. 2018;137:e578–e622. doi: 10.1161/CIR.0000000000000560 - DOI - PubMed
    1. Matsushita K, Ballew SH, Wang AY, Kalyesubula R, Schaeffner E, Agarwal R. Epidemiology and risk of cardiovascular disease in populations with chronic kidney disease. Nat Rev Nephrol. 2022;18:696–707. doi: 10.1038/s41581-022-00616-6 - DOI - PubMed
    1. Wang X, Shapiro JI. Evolving concepts in the pathogenesis of uraemic cardiomyopathy. Nat Rev Nephrol. 2019;15:159–175. doi: 10.1038/s41581-018-0101-8 - DOI - PubMed
    1. Miri M, Ahmadi M, Hatami M. Correlation between fibroblast growth factor‐23 and pulmonary arterial hypertension in hemodialysis patients. Iran J Kidney Dis. 2021;15:300–305. doi: 10.52547/ijkd.5940 - DOI - PubMed
    1. Scialla JJ, Xie H, Rahman M, Anderson AH, Isakova T, Ojo A, Zhang X, Nessel L, Hamano T, Grunwald JE, et al. Fibroblast growth factor‐23 and cardiovascular events in CKD. J Am Soc Nephrol. 2014;25:349–360. doi: 10.1681/ASN.2013050465 - DOI - PMC - PubMed